搜尋結果
FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
CNBC· 2 日前Novo is aiming to be the first to hit the market with a weekly insulin product, offering an ...
Big tech companies are plowing money into AI startups, which could help them dodge antitrust ...
TechCrunch· 3 日前DeepL, an AI language translation startup, raised $300 million on a $2 billion valuation; Scale ...
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
Reuters· 2 日前Novo is aiming to be the first to hit the market with a weekly insulin product, offering an ...
How The Thunder Can Become Championship Favorites By Next Season
Forbes· 6 日前With Shai Gilgeous-Alexander, Jalen Williams, and Chet Holmgren occupying the primary guard, ...
Rafael Nadal Is Not 100% Sure This Will Be His Final French Open
Forbes· 2 日前Rafael Nadal has a message for everything saying and writing that this will be his final French ...
‘Rescue’ role of China’s distressed asset managers questioned amid property woes
South China Morning Post· 4 日前The growing scepticism comes at a critical time when China is seeking to defuse financial ...
Kretinsky weighs changes to Atos bid to win over creditors, source says
Reuters· 6 日前, opens new tab, a source close to the matter said, as the distressed IT firm seeks a debt ...
Stocks making the biggest moves midday: Hims & Hers Health, Norwegian Cruise Line, Target and more
CNBC· 7 日前These are the stocks posting the largest moves in midday trading.
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters· 6 日前Novo Nordisk's popular diabetes drug Ozempic won approval from China in 2021 and the ...
US FDA staff flags risk of low blood sugar for Novo Nordisk's weekly insulin
Reuters· 5 日前, opens new tab long-acting weekly insulin had an increased risk of low blood sugar in patients ...